Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019

BJ Patterson, CC Chen, CB McGuiness… - Human Vaccines & …, 2021 - Taylor & Francis
Shingrix (Recombinant zoster vaccine, RZV) was approved in October 2017 in the United
States (US) for the prevention of herpes zoster in adults aged 50 years and older. The …

Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination

H Voic, RD de Vries, J Sidney, P Rubiro… - Journal of …, 2020 - Am Soc Microbiol
Infections with varicella-zoster virus (VZV) are associated with a range of clinical
manifestations. Primary infection with VZV causes chicken pox. The virus remains latent in …

[HTML][HTML] Immune responses to varicella zoster virus and effective vaccines

SJ Lee, H Kim, KJ Hong, JH Nam - Journal of Bacteriology and …, 2021 - journal-jbv.apub.kr
Varicella zoster virus (VZV) causes two distinct diseases, varicella (chickenpox) during
primary infection, and herpes zoster (shingles) resulting from reactivation. The purpose of …

Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantation

CJ Feng, P Zhao, HX Fu, CH Yan, CC Wang, XL Zhu… - Cancer Letters, 2024 - Elsevier
The incidence of herpes zoster (HZ) in allogeneic hematopoietic stem cell transplantation
(allo-HSCT) recipients is significantly higher than that of the general public. Although routine …

RETRACTED: A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis …

CJ Feng, P Zhao, HX Fu, CH Yan… - American Journal of …, 2024 - Wiley Online Library
Herpes zoster (HZ) refers to the rash appearing on dermatomes due to varicella zoster virus
(VZV) reactivation. The incidence of HZ is significantly higher in allogeneic hematopoietic …

An atlas of dynamic peripheral blood mononuclear cell landscapes in human perioperative anaesthesia/surgery

YY Wang, EQ Chang, RL Zhu, XZ Liu… - Clinical and …, 2022 - Wiley Online Library
Background The number of patients receiving anaesthesia is increasing, but the impact of
general anaesthesia on the patient's immune system remains unclear. The aim of the …

[HTML][HTML] Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4high memory cell proliferation in activated …

AM Haredy, M Takei, S Iwamoto, M Ohno, M Kosaka… - Vaccine, 2019 - Elsevier
Background Herpes zoster (HZ) is caused by reactivation of a latent varicella zoster virus
(VZV). The potential to develop HZ increases with age due to waning of memory cell …

[HTML][HTML] Prophylactic vaccination with a live-attenuated herpes zoster vaccine in lung transplant candidates

L Wang, EAM Verschuuren, D Paap, C Rondaan… - The Journal of Heart and …, 2020 - Elsevier
BACKGROUND Herpes zoster (HZ) is caused by the reactivation of varicella–zoster virus
(VZV). Patients with lung transplants are at high risk for HZ owing to their …

Ageing of immune system and response to a live-attenuated herpes zoster vaccine in lung transplant candidates

L Wang, EAM Verschuuren, D Paap, C Rondaan… - Vaccines, 2021 - mdpi.com
The mean age of lung transplant recipients has significantly increased in recent decades.
Elderly recipients have a higher risk of developing herpes zoster (HZ), and they have in …

Ageing and vaccination in transplant patients

L Wang - 2021 - research.rug.nl
The mean age of transplant recipients has significantly increased the last decennia and
older patients are facing higher risk for infectious complications. Varicella zoster virus (VZV) …